España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
MaxCyte
MXCT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.55
0.1
2.90%
At close: -
$3.55
0
0.00%
After Hours: Nov 22, 4:00 PM EDT
Get Report
Comment
MaxCyte (MXCT) Forecast
News
Earnings
MaxCyte (MXCT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for MaxCyte (NASDAQ:MXCT) Stock
MaxCyte Stock (NASDAQ: MXCT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 06, 2024
MaxCyte Q3 2024 GAAP EPS $(0.11) Beats $(0.12...
Benzinga Newsdesk
MaxCyte expectes FY2024: Core revenue growth ...
Benzinga Newsdesk
Monday, September 16, 2024
MaxCyte and Kamau Therapeutics Enter Strategi...
Benzinga Newsdesk
Tuesday, August 06, 2024
MaxCyte shares are trading higher after the c...
Benzinga Newsdesk
MaxCyte Q2 2024 GAAP EPS $(0.09) Beats $(0.12...
Benzinga Newsdesk
Wednesday, May 22, 2024
MaxCyte Signs License Agreement With Legend B...
Benzinga Newsdesk
Wednesday, May 08, 2024
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
MaxCyte shares are trading higher after the c...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Tuesday, May 07, 2024
MaxCyte Affirms 2024 Revenue Guidance For Cor...
Benzinga Newsdesk
MaxCyte Q1 2024 GAAP EPS $(0.09) Beats $(0.12...
Benzinga Newsdesk
Tuesday, April 23, 2024
Stephens & Co. Reiterates Overweight on MaxCy...
Benzinga Newsdesk
Tuesday, April 02, 2024
MaxCyte Signs Strategic Platform License With...
Benzinga Newsdesk
Wednesday, March 20, 2024
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Wednesday, March 13, 2024
Stephens & Co. Reiterates Overweight on MaxCy...
Benzinga Newsdesk
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
BTIG Maintains Buy on MaxCyte, Lowers Price T...
Benzinga Newsdesk
MaxCyte shares are trading higher after the c...
Benzinga Newsdesk
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Avi Kapoor
Tuesday, March 12, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
MaxCyte shares are trading higher after the c...
Benzinga Newsdesk
MaxCyte Expects FY24 Core Business Revenue To...
Benzinga Newsdesk
MaxCyte Q4 EPS $(0.05) Beats $(0.07) Estimate, Sales $15.66M Beat $13.09M Estimate
Happy Mohamed
Earnings Scheduled For March 12, 2024
Benzinga Insights
Monday, March 11, 2024
MaxCyte Earnings Preview
Benzinga Insights
Tuesday, March 05, 2024
MaxCyte shares are trading lower. The company...
Benzinga Newsdesk
Monday, March 04, 2024
MaxCyte Sees Prelim. FY23 Revenue $41.1M-$41....
Benzinga Newsdesk
MaxCyte Sees FY24 Core Revenue Flat To 5% Gro...
Benzinga Newsdesk
Tuesday, January 30, 2024
MaxCyte And Wugen Sign Strategic Platform Lic...
Benzinga Newsdesk
Tuesday, January 23, 2024
MaxCyte Signs Strategic Platform License With...
Benzinga Newsdesk
Tuesday, January 09, 2024
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Why Cell Engineering Company MaxCyte Shares Are Up Today
Lekha Gupta
Monday, January 08, 2024
MaxCyte shares are trading higher after the c...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
MaxCyte Announces Preliminary Q4 Revenue $15....
Benzinga Newsdesk
Wednesday, January 03, 2024
MaxCyte And Lion TCR Form Partnership To Supp...
Benzinga Newsdesk
Tuesday, January 02, 2024
MaxCyte Confirms Appointment Of Maher Masoud ...
Benzinga Newsdesk
Monday, December 11, 2023
MaxCyte Announces CEO Transition; Doug Doerfl...
Benzinga Newsdesk
Wednesday, December 06, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, November 29, 2023
Craig-Hallum Initiates Coverage On MaxCyte wi...
Benzinga Newsdesk
Wednesday, November 08, 2023
Recap: MaxCyte Q3 Earnings
Benzinga Insights
MaxCyte Q3 2023 EPS $(0.11) Misses $(0.10) Es...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Thursday, October 05, 2023
Cell Engineering MaxCyte Faces Challenge, Analysts Express Concerns Over Near-Term Prospects Amid Revenue Decline
Vandana Singh
Crude Oil Down 2%; ConAgra Brands Earnings Top Views
Lisa Levin
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch